SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-11-000402
Filing Date
2011-05-13
Accepted
2011-05-13 17:14:52
Documents
6
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR 03-31-2011 form_10-q.htm 10-Q 506206
2 RULE 13A-14(A)/ 15D-14(A) CERTIFICATION OF CEO ex_31-1.htm EX-31 5739
3 RULE 13A-14(A)/ 15D-14(A) CERTIFICATION OF CFO ex_31-2.htm EX-31 5712
4 SECTION 1350 CERTIFICATION OF CEO ex_32-1.htm EX-32 2773
5 SECTION 1350 CERTIFICATION OF CFO ex_32-2.htm EX-32 2769
6 GRAPHIC chart.jpg GRAPHIC 19191
  Complete submission text file 0001161697-11-000402.txt   550922
Mailing Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071
Business Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071 86-10-63899868
Lotus Pharmaceuticals, Inc. (Filer) CIK: 0001292087 (see all company filings)

IRS No.: 200507918 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32581 | Film No.: 11842114
SIC: 2834 Pharmaceutical Preparations